Tomáš Frgala

446 total citations
16 papers, 386 citations indexed

About

Tomáš Frgala is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Tomáš Frgala has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Tomáš Frgala's work include Retinoids in leukemia and cellular processes (6 papers), Cancer therapeutics and mechanisms (4 papers) and Estrogen and related hormone effects (3 papers). Tomáš Frgala is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Cancer therapeutics and mechanisms (4 papers) and Estrogen and related hormone effects (3 papers). Tomáš Frgala collaborates with scholars based in United States, Czechia and Canada. Tomáš Frgala's co-authors include C. Patrick Reynolds, Ondrej Kalous, Nino Keshelava, Dalibor Valík, Marta Nekulová, R L Wolfert, Iris Simón, Yingye Zheng, Eleftherios P. Diamandis and Κατερίνα Οικονομοπούλου and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Tomáš Frgala

16 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomáš Frgala United States	11	219	120	80	54	42	16	386
John DeLuca United States	6	227 1.0×	70 0.6×	41 0.5×	70 1.3×	81 1.9×	9	365
Rhj Begent United Kingdom	13	195 0.9×	95 0.8×	42 0.5×	28 0.5×	112 2.7×	30	496
Hao Mo China	13	226 1.0×	135 1.1×	24 0.3×	85 1.6×	42 1.0×	32	436
Sameer A. Greenall Australia	13	203 0.9×	142 1.2×	24 0.3×	91 1.7×	15 0.4×	22	424
Jeffrey Knipstein United States	9	328 1.5×	99 0.8×	56 0.7×	38 0.7×	11 0.3×	15	444
Salvatore A. Del Prete United States	10	307 1.4×	374 3.1×	33 0.4×	154 2.9×	42 1.0×	13	665
Jeffrey Rubens United States	10	399 1.8×	49 0.4×	69 0.9×	52 1.0×	39 0.9×	22	505
Sonal Varma Canada	12	193 0.9×	106 0.9×	39 0.5×	69 1.3×	55 1.3×	32	456
Sherry Yang United States	10	210 1.0×	305 2.5×	17 0.2×	115 2.1×	39 0.9×	32	645
Ioannis Roxanis United Kingdom	10	187 0.9×	306 2.5×	57 0.7×	61 1.1×	29 0.7×	18	553

Countries citing papers authored by Tomáš Frgala

Since Specialization

Citations

This map shows the geographic impact of Tomáš Frgala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Frgala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Frgala more than expected).

Fields of papers citing papers by Tomáš Frgala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Frgala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Frgala. The network helps show where Tomáš Frgala may publish in the future.

Co-authorship network of co-authors of Tomáš Frgala

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Frgala. A scholar is included among the top collaborators of Tomáš Frgala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Frgala. Tomáš Frgala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dubská, Lenka Zdražilová, et al.. (2012). NKT-like cells are expanded in solid tumour patients.. PubMed. 25 Suppl 2. 2S21–5. 11 indexed citations

Petera, Jiřı́, Petr Matula, Petr Paluska, et al.. (2009). High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma – a radiobiological study. Neoplasma. 56(2). 163–168. 11 indexed citations

Οικονομοπούλου, Κατερίνα, Yingye Zheng, Iris Simón, et al.. (2008). Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. British Journal of Cancer. 99(7). 1103–1113. 85 indexed citations

Reynolds, C. Patrick, Tomáš Frgala, Denice Tsao‐Wei, et al.. (2007). High plasma levels of fenretinide (4-HPR) were associated with improved outcome in a phase II study of recurrent ovarian cancer: A study by the California Cancer Consortium. Journal of Clinical Oncology. 25(18_suppl). 5555–5555. 14 indexed citations

Kocáková, Ilona, M. Svoboda, Eva Roubalová, et al.. (2007). Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma.. PubMed. 54(5). 447–53. 14 indexed citations

Frgala, Tomáš, et al.. (2007). A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations. Molecular Cancer Therapeutics. 6(3). 886–897. 91 indexed citations

Maurer, Barry J., Ondrej Kalous, Vazgen Khankaldyyan, et al.. (2007). Improved Oral Delivery ofN-(4-Hydroxyphenyl)Retinamide with a Novel LYM-X-SORB Organized Lipid Complex. Clinical Cancer Research. 13(10). 3079–3086. 53 indexed citations

Frgala, Tomáš, et al.. (2007). Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.. PubMed. 54(5). 413–23. 10 indexed citations

Liu, Xinli, Barry J. Maurer, Tomáš Frgala, et al.. (2007). Preclinical toxicology and pharmacokinetics of intravenous lipid emulsion fenretinide. 6. 3 indexed citations

10.

Petera, Jiřı́, et al.. (2006). High dose rate brachytherapy in the treatment of oral cancer--the preliminary one institution experience.. PubMed. 53(3). 232–6. 7 indexed citations

11.

Petera, Jiřı́, Karel Odrážka, Tomáš Frgala, & Jiří Špaček. (2005). External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma. Gynecologic Oncology. 99(2). 334–338. 10 indexed citations

12.

Keshelava, Nino, et al.. (2005). DIMSCAN: A Microcomputer Fluorescence-Based Cytotoxicity Assay for Preclinical Testing of Combination Chemotherapy. Humana Press eBooks. 139–154. 54 indexed citations

13.

Maurer, Britta, et al.. (2004). Improved oral fenretinide delivery with novel Lym-X-Sorb™ organized lipid complex. Cancer Research. 64. 148–149. 1 indexed citations

14.

García, Agustin A., M. McNamara, Sidney Scudder, et al.. (2004). Phase II trial of fenretinide (4-HPR) in recurrent ovarian and primary peritoneal carcinoma: A California Cancer Consortium trial. Journal of Clinical Oncology. 22(14_suppl). 5056–5056. 2 indexed citations

15.

García, Agustin A., R.J. Morgan, M. McNamara, et al.. (2004). Phase II trial of fenretinide (4-HPR) in recurrent ovarian and primary peritoneal carcinoma: A California Cancer Consortium trial. Journal of Clinical Oncology. 22(14_suppl). 5056–5056. 6 indexed citations

16.

Jong, Ambrose, Kefei Yu, Bingsen Zhou, et al.. (1998). A simple and sensitive ribonucleotide reductase assay. Journal of Biomedical Science. 5(1). 62–68. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact